Suzetrigine for rib fractures

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Aug 2025: Trial registered, NCT07145346
  2. 13 Nov 2025: Trial started, NCT07145346

The trials

NCT07145346: Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures

State
Under way
Phase
Phase 4
People
80 planned
Started
13 Nov 2025
Primary completion
Aug 2027
Arms
Suzetrigine arm
Results
None posted
  1. 28 Aug 2025: Trial registered
  2. 13 Nov 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Journavx, Suz, Suzetrigine (Journavx), Suzetrigine (SUZ), Suzetrigine Group, oral suzetrigine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.